Global Oncolytic Virus Therapy for Melanoma Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Oncolytic Virus Therapy for Melanoma market size was valued at US$ 148 million in 2024 and is forecast to a readjusted size of USD 615 million by 2031 with a CAGR of 21.5% during review period.
Oncolytic virus therapy for melanoma is an innovative cancer treatment approach. Oncolytic viruses are either genetically engineered or naturally - occurring viruses that can selectively target and replicate within melanoma cells while minimizing damage to normal cells. These viruses have the ability to preferentially infect tumor cells because melanoma cells possess unique biological characteristics. For example, they have active cell - proliferation signaling pathways, defective antiviral immune responses, and certain specific cell - surface receptors. These features enable oncolytic viruses to more easily enter and replicate within melanoma cells.
This report is a detailed and comprehensive analysis for global Oncolytic Virus Therapy for Melanoma market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncolytic Virus Therapy for Melanoma market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus Therapy for Melanoma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus Therapy for Melanoma market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Rigvir, Replimune (Pipeline), Takara Bio (Pipeline), Wuhan Binhui Biotechnology (Pipeline), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncolytic Virus Therapy for Melanoma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Therapy for Melanoma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Therapy for Melanoma, with revenue, gross margin, and global market share of Oncolytic Virus Therapy for Melanoma from 2020 to 2025.
Chapter 3, the Oncolytic Virus Therapy for Melanoma competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncolytic Virus Therapy for Melanoma market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Therapy for Melanoma.
Chapter 13, to describe Oncolytic Virus Therapy for Melanoma research findings and conclusion.
Oncolytic virus therapy for melanoma is an innovative cancer treatment approach. Oncolytic viruses are either genetically engineered or naturally - occurring viruses that can selectively target and replicate within melanoma cells while minimizing damage to normal cells. These viruses have the ability to preferentially infect tumor cells because melanoma cells possess unique biological characteristics. For example, they have active cell - proliferation signaling pathways, defective antiviral immune responses, and certain specific cell - surface receptors. These features enable oncolytic viruses to more easily enter and replicate within melanoma cells.
This report is a detailed and comprehensive analysis for global Oncolytic Virus Therapy for Melanoma market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncolytic Virus Therapy for Melanoma market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncolytic Virus Therapy for Melanoma market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus Therapy for Melanoma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus Therapy for Melanoma market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Rigvir, Replimune (Pipeline), Takara Bio (Pipeline), Wuhan Binhui Biotechnology (Pipeline), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncolytic Virus Therapy for Melanoma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- HSV Virus
- EHCO Virus
- Others
- Melanoma Treatment
- Recurrence and Metastasis Prevention
- Amgen
- Rigvir
- Replimune (Pipeline)
- Takara Bio (Pipeline)
- Wuhan Binhui Biotechnology (Pipeline)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Therapy for Melanoma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Therapy for Melanoma, with revenue, gross margin, and global market share of Oncolytic Virus Therapy for Melanoma from 2020 to 2025.
Chapter 3, the Oncolytic Virus Therapy for Melanoma competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncolytic Virus Therapy for Melanoma market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Therapy for Melanoma.
Chapter 13, to describe Oncolytic Virus Therapy for Melanoma research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus Therapy for Melanoma by Type
1.3.1 Overview: Global Oncolytic Virus Therapy for Melanoma Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type in 2024
1.3.3 HSV Virus
1.3.4 EHCO Virus
1.3.5 Others
1.4 Global Oncolytic Virus Therapy for Melanoma Market by Application
1.4.1 Overview: Global Oncolytic Virus Therapy for Melanoma Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Melanoma Treatment
1.4.3 Recurrence and Metastasis Prevention
1.5 Global Oncolytic Virus Therapy for Melanoma Market Size & Forecast
1.6 Global Oncolytic Virus Therapy for Melanoma Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Therapy for Melanoma Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oncolytic Virus Therapy for Melanoma Market Size by Region, (2020-2031)
1.6.3 North America Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.4 Europe Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.6 South America Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Oncolytic Virus Therapy for Melanoma Product and Solutions
2.1.4 Amgen Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Rigvir
2.2.1 Rigvir Details
2.2.2 Rigvir Major Business
2.2.3 Rigvir Oncolytic Virus Therapy for Melanoma Product and Solutions
2.2.4 Rigvir Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Rigvir Recent Developments and Future Plans
2.3 Replimune (Pipeline)
2.3.1 Replimune (Pipeline) Details
2.3.2 Replimune (Pipeline) Major Business
2.3.3 Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
2.3.4 Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Replimune (Pipeline) Recent Developments and Future Plans
2.4 Takara Bio (Pipeline)
2.4.1 Takara Bio (Pipeline) Details
2.4.2 Takara Bio (Pipeline) Major Business
2.4.3 Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
2.4.4 Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takara Bio (Pipeline) Recent Developments and Future Plans
2.5 Wuhan Binhui Biotechnology (Pipeline)
2.5.1 Wuhan Binhui Biotechnology (Pipeline) Details
2.5.2 Wuhan Binhui Biotechnology (Pipeline) Major Business
2.5.3 Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
2.5.4 Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Wuhan Binhui Biotechnology (Pipeline) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncolytic Virus Therapy for Melanoma Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oncolytic Virus Therapy for Melanoma by Company Revenue
3.2.2 Top 3 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
3.2.3 Top 6 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
3.3 Oncolytic Virus Therapy for Melanoma Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Therapy for Melanoma Market: Region Footprint
3.3.2 Oncolytic Virus Therapy for Melanoma Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Therapy for Melanoma Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncolytic Virus Therapy for Melanoma Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oncolytic Virus Therapy for Melanoma Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2025)
5.2 Global Oncolytic Virus Therapy for Melanoma Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
6.2 North America Oncolytic Virus Therapy for Melanoma Market Size by Application (2020-2031)
6.3 North America Oncolytic Virus Therapy for Melanoma Market Size by Country
6.3.1 North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
6.3.2 United States Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
6.3.3 Canada Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
6.3.4 Mexico Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
7.2 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
7.3 Europe Oncolytic Virus Therapy for Melanoma Market Size by Country
7.3.1 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
7.3.2 Germany Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.3 France Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.5 Russia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.6 Italy Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oncolytic Virus Therapy for Melanoma Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2031)
8.3.2 China Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.3 Japan Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.4 South Korea Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.5 India Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.7 Australia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
9.2 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
9.3 South America Oncolytic Virus Therapy for Melanoma Market Size by Country
9.3.1 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
9.3.2 Brazil Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
9.3.3 Argentina Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oncolytic Virus Therapy for Melanoma Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
10.3.2 Turkey Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10.3.4 UAE Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Oncolytic Virus Therapy for Melanoma Market Drivers
11.2 Oncolytic Virus Therapy for Melanoma Market Restraints
11.3 Oncolytic Virus Therapy for Melanoma Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncolytic Virus Therapy for Melanoma Industry Chain
12.2 Oncolytic Virus Therapy for Melanoma Upstream Analysis
12.3 Oncolytic Virus Therapy for Melanoma Midstream Analysis
12.4 Oncolytic Virus Therapy for Melanoma Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus Therapy for Melanoma by Type
1.3.1 Overview: Global Oncolytic Virus Therapy for Melanoma Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type in 2024
1.3.3 HSV Virus
1.3.4 EHCO Virus
1.3.5 Others
1.4 Global Oncolytic Virus Therapy for Melanoma Market by Application
1.4.1 Overview: Global Oncolytic Virus Therapy for Melanoma Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Melanoma Treatment
1.4.3 Recurrence and Metastasis Prevention
1.5 Global Oncolytic Virus Therapy for Melanoma Market Size & Forecast
1.6 Global Oncolytic Virus Therapy for Melanoma Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Therapy for Melanoma Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oncolytic Virus Therapy for Melanoma Market Size by Region, (2020-2031)
1.6.3 North America Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.4 Europe Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.6 South America Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oncolytic Virus Therapy for Melanoma Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Oncolytic Virus Therapy for Melanoma Product and Solutions
2.1.4 Amgen Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Rigvir
2.2.1 Rigvir Details
2.2.2 Rigvir Major Business
2.2.3 Rigvir Oncolytic Virus Therapy for Melanoma Product and Solutions
2.2.4 Rigvir Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Rigvir Recent Developments and Future Plans
2.3 Replimune (Pipeline)
2.3.1 Replimune (Pipeline) Details
2.3.2 Replimune (Pipeline) Major Business
2.3.3 Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
2.3.4 Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Replimune (Pipeline) Recent Developments and Future Plans
2.4 Takara Bio (Pipeline)
2.4.1 Takara Bio (Pipeline) Details
2.4.2 Takara Bio (Pipeline) Major Business
2.4.3 Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
2.4.4 Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takara Bio (Pipeline) Recent Developments and Future Plans
2.5 Wuhan Binhui Biotechnology (Pipeline)
2.5.1 Wuhan Binhui Biotechnology (Pipeline) Details
2.5.2 Wuhan Binhui Biotechnology (Pipeline) Major Business
2.5.3 Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
2.5.4 Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Wuhan Binhui Biotechnology (Pipeline) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncolytic Virus Therapy for Melanoma Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oncolytic Virus Therapy for Melanoma by Company Revenue
3.2.2 Top 3 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
3.2.3 Top 6 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
3.3 Oncolytic Virus Therapy for Melanoma Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Therapy for Melanoma Market: Region Footprint
3.3.2 Oncolytic Virus Therapy for Melanoma Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Therapy for Melanoma Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncolytic Virus Therapy for Melanoma Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oncolytic Virus Therapy for Melanoma Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2025)
5.2 Global Oncolytic Virus Therapy for Melanoma Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
6.2 North America Oncolytic Virus Therapy for Melanoma Market Size by Application (2020-2031)
6.3 North America Oncolytic Virus Therapy for Melanoma Market Size by Country
6.3.1 North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
6.3.2 United States Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
6.3.3 Canada Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
6.3.4 Mexico Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
7.2 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
7.3 Europe Oncolytic Virus Therapy for Melanoma Market Size by Country
7.3.1 Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
7.3.2 Germany Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.3 France Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.5 Russia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
7.3.6 Italy Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oncolytic Virus Therapy for Melanoma Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2031)
8.3.2 China Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.3 Japan Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.4 South Korea Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.5 India Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
8.3.7 Australia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
9.2 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
9.3 South America Oncolytic Virus Therapy for Melanoma Market Size by Country
9.3.1 South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
9.3.2 Brazil Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
9.3.3 Argentina Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oncolytic Virus Therapy for Melanoma Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2031)
10.3.2 Turkey Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
10.3.4 UAE Oncolytic Virus Therapy for Melanoma Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Oncolytic Virus Therapy for Melanoma Market Drivers
11.2 Oncolytic Virus Therapy for Melanoma Market Restraints
11.3 Oncolytic Virus Therapy for Melanoma Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncolytic Virus Therapy for Melanoma Industry Chain
12.2 Oncolytic Virus Therapy for Melanoma Upstream Analysis
12.3 Oncolytic Virus Therapy for Melanoma Midstream Analysis
12.4 Oncolytic Virus Therapy for Melanoma Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 8. Amgen Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Rigvir Company Information, Head Office, and Major Competitors
Table 11. Rigvir Major Business
Table 12. Rigvir Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 13. Rigvir Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Rigvir Recent Developments and Future Plans
Table 15. Replimune (Pipeline) Company Information, Head Office, and Major Competitors
Table 16. Replimune (Pipeline) Major Business
Table 17. Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 18. Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Takara Bio (Pipeline) Company Information, Head Office, and Major Competitors
Table 20. Takara Bio (Pipeline) Major Business
Table 21. Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 22. Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Takara Bio (Pipeline) Recent Developments and Future Plans
Table 24. Wuhan Binhui Biotechnology (Pipeline) Company Information, Head Office, and Major Competitors
Table 25. Wuhan Binhui Biotechnology (Pipeline) Major Business
Table 26. Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 27. Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Wuhan Binhui Biotechnology (Pipeline) Recent Developments and Future Plans
Table 29. Global Oncolytic Virus Therapy for Melanoma Revenue (USD Million) by Players (2020-2025)
Table 30. Global Oncolytic Virus Therapy for Melanoma Revenue Share by Players (2020-2025)
Table 31. Breakdown of Oncolytic Virus Therapy for Melanoma by Company Type (Tier 1, Tier 2, and Tier 3)
Table 32. Market Position of Players in Oncolytic Virus Therapy for Melanoma, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 33. Head Office of Key Oncolytic Virus Therapy for Melanoma Players
Table 34. Oncolytic Virus Therapy for Melanoma Market: Company Product Type Footprint
Table 35. Oncolytic Virus Therapy for Melanoma Market: Company Product Application Footprint
Table 36. Oncolytic Virus Therapy for Melanoma New Market Entrants and Barriers to Market Entry
Table 37. Oncolytic Virus Therapy for Melanoma Mergers, Acquisition, Agreements, and Collaborations
Table 38. Global Oncolytic Virus Therapy for Melanoma Consumption Value (USD Million) by Type (2020-2025)
Table 39. Global Oncolytic Virus Therapy for Melanoma Consumption Value Share by Type (2020-2025)
Table 40. Global Oncolytic Virus Therapy for Melanoma Consumption Value Forecast by Type (2026-2031)
Table 41. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025)
Table 42. Global Oncolytic Virus Therapy for Melanoma Consumption Value Forecast by Application (2026-2031)
Table 43. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 44. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 45. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 46. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 47. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 48. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 49. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 50. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 51. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 52. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 53. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 54. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 55. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 56. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 57. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2025) & (USD Million)
Table 60. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2026-2031) & (USD Million)
Table 61. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 62. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 63. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 64. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 65. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 66. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 67. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 68. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 69. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 70. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 71. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 72. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 73. Global Key Players of Oncolytic Virus Therapy for Melanoma Upstream (Raw Materials)
Table 74. Global Oncolytic Virus Therapy for Melanoma Typical Customers
Table 1. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 8. Amgen Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Rigvir Company Information, Head Office, and Major Competitors
Table 11. Rigvir Major Business
Table 12. Rigvir Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 13. Rigvir Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Rigvir Recent Developments and Future Plans
Table 15. Replimune (Pipeline) Company Information, Head Office, and Major Competitors
Table 16. Replimune (Pipeline) Major Business
Table 17. Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 18. Replimune (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Takara Bio (Pipeline) Company Information, Head Office, and Major Competitors
Table 20. Takara Bio (Pipeline) Major Business
Table 21. Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 22. Takara Bio (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Takara Bio (Pipeline) Recent Developments and Future Plans
Table 24. Wuhan Binhui Biotechnology (Pipeline) Company Information, Head Office, and Major Competitors
Table 25. Wuhan Binhui Biotechnology (Pipeline) Major Business
Table 26. Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Product and Solutions
Table 27. Wuhan Binhui Biotechnology (Pipeline) Oncolytic Virus Therapy for Melanoma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Wuhan Binhui Biotechnology (Pipeline) Recent Developments and Future Plans
Table 29. Global Oncolytic Virus Therapy for Melanoma Revenue (USD Million) by Players (2020-2025)
Table 30. Global Oncolytic Virus Therapy for Melanoma Revenue Share by Players (2020-2025)
Table 31. Breakdown of Oncolytic Virus Therapy for Melanoma by Company Type (Tier 1, Tier 2, and Tier 3)
Table 32. Market Position of Players in Oncolytic Virus Therapy for Melanoma, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 33. Head Office of Key Oncolytic Virus Therapy for Melanoma Players
Table 34. Oncolytic Virus Therapy for Melanoma Market: Company Product Type Footprint
Table 35. Oncolytic Virus Therapy for Melanoma Market: Company Product Application Footprint
Table 36. Oncolytic Virus Therapy for Melanoma New Market Entrants and Barriers to Market Entry
Table 37. Oncolytic Virus Therapy for Melanoma Mergers, Acquisition, Agreements, and Collaborations
Table 38. Global Oncolytic Virus Therapy for Melanoma Consumption Value (USD Million) by Type (2020-2025)
Table 39. Global Oncolytic Virus Therapy for Melanoma Consumption Value Share by Type (2020-2025)
Table 40. Global Oncolytic Virus Therapy for Melanoma Consumption Value Forecast by Type (2026-2031)
Table 41. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025)
Table 42. Global Oncolytic Virus Therapy for Melanoma Consumption Value Forecast by Application (2026-2031)
Table 43. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 44. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 45. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 46. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 47. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 48. North America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 49. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 50. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 51. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 52. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 53. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 54. Europe Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 55. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 56. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 57. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2020-2025) & (USD Million)
Table 60. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value by Region (2026-2031) & (USD Million)
Table 61. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 62. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 63. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 64. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 65. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 66. South America Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 67. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2020-2025) & (USD Million)
Table 68. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Type (2026-2031) & (USD Million)
Table 69. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2020-2025) & (USD Million)
Table 70. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Application (2026-2031) & (USD Million)
Table 71. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2020-2025) & (USD Million)
Table 72. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value by Country (2026-2031) & (USD Million)
Table 73. Global Key Players of Oncolytic Virus Therapy for Melanoma Upstream (Raw Materials)
Table 74. Global Oncolytic Virus Therapy for Melanoma Typical Customers
LIST OF FIGURES
Figure 1. Oncolytic Virus Therapy for Melanoma Picture
Figure 2. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type in 2024
Figure 4. HSV Virus
Figure 5. EHCO Virus
Figure 6. Others
Figure 7. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application in 2024
Figure 9. Melanoma Treatment Picture
Figure 10. Recurrence and Metastasis Prevention Picture
Figure 11. Global Oncolytic Virus Therapy for Melanoma Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Oncolytic Virus Therapy for Melanoma Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market Oncolytic Virus Therapy for Melanoma Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Region in 2024
Figure 16. North America Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Oncolytic Virus Therapy for Melanoma Revenue Share by Players in 2024
Figure 23. Oncolytic Virus Therapy for Melanoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of Oncolytic Virus Therapy for Melanoma by Player Revenue in 2024
Figure 25. Top 3 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
Figure 26. Top 6 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
Figure 27. Global Oncolytic Virus Therapy for Melanoma Consumption Value Share by Type (2020-2025)
Figure 28. Global Oncolytic Virus Therapy for Melanoma Market Share Forecast by Type (2026-2031)
Figure 29. Global Oncolytic Virus Therapy for Melanoma Consumption Value Share by Application (2020-2025)
Figure 30. Global Oncolytic Virus Therapy for Melanoma Market Share Forecast by Application (2026-2031)
Figure 31. North America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 32. North America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 41. France Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Region (2020-2031)
Figure 48. China Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 51. India Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 55. South America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 65. Oncolytic Virus Therapy for Melanoma Market Drivers
Figure 66. Oncolytic Virus Therapy for Melanoma Market Restraints
Figure 67. Oncolytic Virus Therapy for Melanoma Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Oncolytic Virus Therapy for Melanoma Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Oncolytic Virus Therapy for Melanoma Picture
Figure 2. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type in 2024
Figure 4. HSV Virus
Figure 5. EHCO Virus
Figure 6. Others
Figure 7. Global Oncolytic Virus Therapy for Melanoma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application in 2024
Figure 9. Melanoma Treatment Picture
Figure 10. Recurrence and Metastasis Prevention Picture
Figure 11. Global Oncolytic Virus Therapy for Melanoma Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Oncolytic Virus Therapy for Melanoma Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market Oncolytic Virus Therapy for Melanoma Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Region in 2024
Figure 16. North America Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Oncolytic Virus Therapy for Melanoma Revenue Share by Players in 2024
Figure 23. Oncolytic Virus Therapy for Melanoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of Oncolytic Virus Therapy for Melanoma by Player Revenue in 2024
Figure 25. Top 3 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
Figure 26. Top 6 Oncolytic Virus Therapy for Melanoma Players Market Share in 2024
Figure 27. Global Oncolytic Virus Therapy for Melanoma Consumption Value Share by Type (2020-2025)
Figure 28. Global Oncolytic Virus Therapy for Melanoma Market Share Forecast by Type (2026-2031)
Figure 29. Global Oncolytic Virus Therapy for Melanoma Consumption Value Share by Application (2020-2025)
Figure 30. Global Oncolytic Virus Therapy for Melanoma Market Share Forecast by Application (2026-2031)
Figure 31. North America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 32. North America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 41. France Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Region (2020-2031)
Figure 48. China Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 51. India Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 55. South America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Oncolytic Virus Therapy for Melanoma Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Oncolytic Virus Therapy for Melanoma Consumption Value (2020-2031) & (USD Million)
Figure 65. Oncolytic Virus Therapy for Melanoma Market Drivers
Figure 66. Oncolytic Virus Therapy for Melanoma Market Restraints
Figure 67. Oncolytic Virus Therapy for Melanoma Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Oncolytic Virus Therapy for Melanoma Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
